Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

T-cell-based therapies for malignancy and infection in childhood.

Ahmed N, Heslop HE, Mackall CL.

Pediatr Clin North Am. 2010 Feb;57(1):83-96. doi: 10.1016/j.pcl.2009.11.002. Review.

2.

Adoptive T-cell transfer in cancer immunotherapy.

Tey SK, Bollard CM, Heslop HE.

Immunol Cell Biol. 2006 Jun;84(3):281-9. Review.

PMID:
16681825
3.

T cell-based therapies for EBV-associated malignancies.

Taylor GS.

Expert Opin Biol Ther. 2004 Jan;4(1):11-21. Review.

PMID:
14680465
4.

Immunotherapy of hematologic malignancy.

Heslop HE, Stevenson FK, Molldrem JJ.

Hematology Am Soc Hematol Educ Program. 2003:331-49. Review.

PMID:
14633789
5.

Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.

Marcus A, Eshhar Z.

Expert Opin Biol Ther. 2014 Jul;14(7):947-54. doi: 10.1517/14712598.2014.900540. Epub 2014 Mar 24. Review.

PMID:
24661086
6.

Adoptive cellular immunotherapy for childhood malignancies.

Cooper LJ.

Bone Marrow Transplant. 2008 Jan;41(2):183-92. Epub 2007 Nov 19. Review.

PMID:
18026145
7.

Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Review.

PMID:
25901860
8.

Improving T cell therapy for cancer.

Leen AM, Rooney CM, Foster AE.

Annu Rev Immunol. 2007;25:243-65. Review.

PMID:
17129181
9.

Generation of tumor-specific T-cell therapies.

Morris E, Hart D, Gao L, Tsallios A, Xue SA, Stauss H.

Blood Rev. 2006 Mar;20(2):61-9. Epub 2005 Jun 22. Review.

PMID:
15978709
10.

Adoptive transfer of virus-specific and tumor-specific T cell immunity.

Berger C, Turtle CJ, Jensen MC, Riddell SR.

Curr Opin Immunol. 2009 Apr;21(2):224-32. doi: 10.1016/j.coi.2009.02.010. Epub 2009 Mar 21. Review.

11.

Antigen-specific T cell therapies for cancer.

Manzo T, Heslop HE, Rooney CM.

Hum Mol Genet. 2015 Oct 15;24(R1):R67-73. doi: 10.1093/hmg/ddv270. Epub 2015 Jul 9. Review.

12.

Improving T cell therapy for cancer.

Foster AE, Rooney CM.

Expert Opin Biol Ther. 2006 Mar;6(3):215-29. Review.

PMID:
16503732
13.

Principles of adoptive T cell cancer therapy.

June CH.

J Clin Invest. 2007 May;117(5):1204-12. Review.

14.

Adoptive T-cell therapy for B-cell malignancies.

Hudecek M, Anderson LD Jr, Nishida T, Riddell SR.

Expert Rev Hematol. 2009 Oct;2(5):517-32. doi: 10.1586/ehm.09.47. Review.

15.

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease.

Bollard CM, Savoldo B, Rooney CM, Heslop HE.

Acta Haematol. 2003;110(2-3):139-48. Review.

PMID:
14583674
16.

Post-transplant adoptive T-cell immunotherapy.

Aqui NA, June CH.

Best Pract Res Clin Haematol. 2008 Sep;21(3):503-19. doi: 10.1016/j.beha.2008.07.001. Review.

17.

The use of endogenous T cells for adoptive transfer.

Yee C.

Immunol Rev. 2014 Jan;257(1):250-63. doi: 10.1111/imr.12134. Review.

PMID:
24329802
18.

Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.

Heslop HE, Savoldo B, Rooney CM.

Best Pract Res Clin Haematol. 2004 Sep;17(3):401-13. Review.

PMID:
15498712
19.

The Evolution of T-cell Therapies for Solid Malignancies.

Fousek K, Ahmed N.

Clin Cancer Res. 2015 Aug 1;21(15):3384-92. doi: 10.1158/1078-0432.CCR-14-2675. Review.

20.

Supplemental Content

Support Center